ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/082/SRR30128782/SRR30128782_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/084/SRR30128784/SRR30128784_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/088/SRR30128788/SRR30128788_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/086/SRR30128786/SRR30128786_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/088/SRR30128788/SRR30128788_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/083/SRR30128783/SRR30128783_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/085/SRR30128785/SRR30128785_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/082/SRR30128782/SRR30128782_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/081/SRR30128781/SRR30128781_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/087/SRR30128787/SRR30128787_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/089/SRR30128789/SRR30128789_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/085/SRR30128785/SRR30128785_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/081/SRR30128781/SRR30128781_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/087/SRR30128787/SRR30128787_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/083/SRR30128783/SRR30128783_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/084/SRR30128784/SRR30128784_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/089/SRR30128789/SRR30128789_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR301/086/SRR30128786/SRR30128786_1.fastq.gzprimary200OKGenomicsSun Yat sen University (Shenzhen Campus)https://www.ebi.ac.uk/ena/browser/view/PRJNA1144210Our findings demonstrate that CHE exerts dual inhibition of AlaRS function, affecting both canonical translational activity and non-canonical roles in cellular signaling, thereby presenting a robust anti-proliferative effect on HNSCC cells.ENAfalseDual Inhibition of AlaRS Function by Chelerythrine as a Therapeutic Strategy for Head and Neck Squamous Cell Carcinoma2025-05-032025-05-03PRJNA1144210